Literature DB >> 18154595

Mucosal innate immunity as a determinant of HIV susceptibility.

Shehzad M Iqbal1, Rupert Kaul.   

Abstract

Most human immunodeficiency virus (HIV) is acquired during sex, across a mucosal membrane. Despite many advances in our understanding of HIV pathogenesis, the initial events during mucosal transmission have been poorly characterized, and a better understanding of these events will probably be a key to the development of successful microbicide(s) and/or a preventative HIV vaccine. While a vast majority of mucosal HIV exposures do not result in productive infection, implying that innate mucosal immune defenses are highly protective, failure of these mucosal defenses resulted in over 3 million new HIV infections in 2006. We review recent findings regarding HIV mucosal immunopathogenesis, emphasizing the importance of innate immunity in natural protection from infection, and examine how natural or induced perturbations in the mucosal innate system may underpin HIV transmission. Given the great challenges to the development of HIV microbicides and vaccines, identification and enhancement of 'natural' innate immune defenses present attractive avenues for development of safe, non-toxic microbicides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154595     DOI: 10.1111/j.1600-0897.2007.00563.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  24 in total

1.  Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety.

Authors:  Anna-Barbara Moscicki; Rupert Kaul; Yifei Ma; Mark E Scott; Ibrahim I Daud; Elizabeth A Bukusi; Stephen Shiboski; Anuradha Rebbapragada; Sanja Huibner; Craig R Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

2.  Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.

Authors:  H Irene Su; Courtney A Schreiber; Courtney Fay; Sam Parry; Michal A Elovitz; Jian Zhang; Alka Shaunik; Kurt Barnhart
Journal:  Contraception       Date:  2011-03-29       Impact factor: 3.375

3.  Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Authors:  Dara A Lehman; Keshet Ronen; Catherine A Blish; Jared M Baeten; Zahra Jalalian-Lechak; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; R Scott McClelland; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

Review 4.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

5.  Molecular immune signatures of HIV-1 vaccines in human PBMCs.

Authors:  Alessandro Monaco; Francesco M Marincola; Marianna Sabatino; Zoltan Pos; Maria Lina Tornesello; David F Stroncek; Ena Wang; George K Lewis; Franco M Buonaguro; Luigi Buonaguro
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

6.  Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

Authors:  Erin M Kahle; Michael Bolton; James P Hughes; Deborah Donnell; Connie Celum; Jairam R Lingappa; Allan Ronald; Craig R Cohen; Guy de Bruyn; Youyi Fong; Elly Katabira; M Juliana McElrath; Jared M Baeten
Journal:  J Infect Dis       Date:  2014-11-10       Impact factor: 5.226

7.  Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa.

Authors:  Nico Nagelkerke; Sake J de Vlas; Prabhat Jha; Ma Luo; Francis A Plummer; Rupert Kaul
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

8.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility.

Authors:  Rupert Kaul; Anuradha Rebbapragada; Taha Hirbod; Charles Wachihi; Terry B Ball; Francis A Plummer; Joshua Kimani; Walter Jaoko
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

Review 10.  Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.